Systematic Review of Clinical Prediction Models for the Risk of Emergency Caesarean Births
Alexandra Hunt,Laura Bonnett,Jon Heron,Michael Lawton,Gemma Clayton,Gordon Smith,Jane Norman,Louise Kenny,Deborah Lawlor,Abi Merriel,the Options Study Collaborative Group,Sheelagh McGuiness,Anna Davies,Dame Tina Lavender,Christy Burden,Jonathan Ives,Simon Grant,Sherif Abdel‐Fattah,Danya Bakhbakhi,Andrew Demetri,Mairead Black,Sam Finnikin,Amie Wilson,Alexandra Freeman,Pete Blair,Kate Birchenall,Joanne Johnson,Amber Marshall
DOI: https://doi.org/10.1111/1471-0528.17948
2024-09-11
BJOG An International Journal of Obstetrics & Gynaecology
Abstract:Background Globally, caesarean births (CB), including emergency caesareans births (EmCB), are rising. It is estimated that nearly a third of all births will be CB by 2030. Objectives Identify and summarise the results from studies developing and validating prognostic multivariable models predicting the risk of EmCBs. Ultimately understanding the accuracy of their development, and whether they are operationalised for use in routine clinical practice. Search Strategy Studies were identified using databases: MEDLINE, CINAHL, Cochrane Central and Scopus with a search strategy tailored to models predicting EmCBs. Selection Criteria Prospective studies developing and validating clinical prediction models, with two or more covariates, to predict risk of EmCB. Data Collection and Analysis Data were extracted onto a proforma using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). Results In total, 8083 studies resulted in 56 unique prediction modelling studies and seven validating studies, with a total of 121 different predictors. Frequently occurring predictors included maternal height, maternal age, parity, BMI and gestational age. PROBAST highlighted 33 studies with low overall bias, and these all internally validated their model. Thirteen studies externally validated; only eight of these were graded an overall low risk of bias. Six models offered applications that could be readily used, but only one provided enough time to offer a planned caesarean birth (pCB). These well‐refined models have not been recalibrated since development. Only one model, developed in a relatively low‐risk population, with data collected a decade ago, remains useful at 36 weeks for arranging a pCB. Conclusion To improve personalised clinical conversations, there is a pressing need for a model that accurately predicts the timely risk of an EmCB for women across diverse clinical backgrounds. Trial Registration: PROSPERO registration number: CRD42023384439.
obstetrics & gynecology